| Aryl hydrocarbon receptor signaling cell intrinsically inhibits intestinal group 2 innate lymphoid cell function S Li, JW Bostick, J Ye, J Qiu, B Zhang, JF Urban, D Avram, L Zhou Immunity 49 (5), 915-928. e5, 2018 | 164 | 2018 |
| The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells J Ye, J Qiu, JW Bostick, A Ueda, H Schjerven, S Li, C Jobin, ... Cell reports 21 (8), 2277-2290, 2017 | 147 | 2017 |
| Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease X Du, H Shi, J Li, Y Dong, JL Liang, J Ye, S Kong, S Zhang, T Zhong, ... The Journal of Immunology 192 (4), 1525-1535, 2014 | 141 | 2014 |
| A cell-intrinsic role for Mst1 in regulating thymocyte egress Y Dong, X Du, J Ye, M Han, T Xu, Y Zhuang, W Tao The Journal of Immunology 183 (6), 3865-3872, 2009 | 124 | 2009 |
| Selective ablation of cancer cells with low intensity pulsed ultrasound DR Mittelstein, J Ye, EF Schibber, A Roychoudhury, LT Martinez, ... Applied Physics Letters 116 (1), 2020 | 77 | 2020 |
| Clinical response to immunotherapy targeting programmed cell death receptor 1/programmed cell death ligand 1 in patients with treatment-resistant microsatellite stable … C Wang, J Sandhu, C Ouyang, J Ye, PP Lee, M Fakih JAMA network Open 4 (8), e2118416-e2118416, 2021 | 69 | 2021 |
| Requirement of mitochondrial transcription factor A in tissue-resident regulatory T cell maintenance and function Z Fu, J Ye, JW Dean, JW Bostick, SE Weinberg, L Xiong, KN Oliff, ... Cell reports 28 (1), 159-171. e4, 2019 | 59 | 2019 |
| Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15 L Xiong, JW Dean, Z Fu, KN Oliff, JW Bostick, J Ye, ZE Chen, ... Science immunology 5 (48), eaaz7277, 2020 | 50 | 2020 |
| Ablation of Vacuole Protein Sorting 18 (Vps18) Gene Leads to Neurodegeneration and Impaired Neuronal Migration by Disrupting Multiple Vesicle Transport Pathways to Lysosomes*♦ C Peng, J Ye, S Yan, S Kong, Y Shen, C Li, Q Li, Y Zheng, K Deng, T Xu, ... Journal of Biological Chemistry 287 (39), 32861-32873, 2012 | 46 | 2012 |
| Warburg effect is a cancer immune evasion mechanism against macrophage immunosurveillance J Chen, X Cao, B Li, Z Zhao, S Chen, SWT Lai, SA Muend, GK Nossa, ... Frontiers in immunology 11, 621757, 2021 | 29 | 2021 |
| Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive … C Egelston, W Guo, S Yost, JS Lee, D Rose, C Avalos, J Ye, P Frankel, ... Journal for Immunotherapy of Cancer 9 (3), 2021 | 19 | 2021 |
| PP6 controls T cell development and homeostasis by negatively regulating distal TCR signaling J Ye, H Shi, Y Shen, C Peng, Y Liu, C Li, K Deng, J Geng, T Xu, Y Zhuang, ... The Journal of Immunology 194 (4), 1654-1664, 2015 | 18 | 2015 |
| PD-L1 and ICOSL discriminate human secretory and helper dendritic cells in cancer, allergy and autoimmunity C Hoffmann, F Noel, M Grandclaudon, L Massenet-Regad, P Michea, ... Nature Communications 13 (1), 1983, 2022 | 14 | 2022 |
| Talimogene Laherparepvec (T-VEC): a review of the recent advances in cancer therapy T Zhang, THT Jou, J Hsin, Z Wang, K Huang, J Ye, H Yin, Y Xing Journal of Clinical Medicine 12 (3), 1098, 2023 | 13 | 2023 |
| Vps18 deficiency inhibits dendritogenesis in Purkinje cells by blocking the lysosomal degradation of Lysyl Oxidase C Peng, S Yan, J Ye, L Shen, T Xu, W Tao Biochemical and biophysical research communications 423 (4), 715-720, 2012 | 11 | 2012 |
| B cell receptor signaling strength modulates cancer immunity J Ye, PP Lee The Journal of Clinical Investigation 132 (6), 2022 | 9 | 2022 |
| 495P Lack of liver metastases identifies a group of MSS metastatic colorectal cancer with potential benefit from PD-1/PD-L1 targeting M Fakih, JS Sandhu, C Wang, J Ye, P Lee Annals of Oncology 31, S450-S451, 2020 | 4 | 2020 |
| Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases M Fakih, C Wang, J Sandhu, J Ye, C Egelston, X Li European Journal of Cancer 196, 113437, 2024 | 1 | 2024 |
| exploratory biomarker analyses in phase 1 study of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant microsatellite stable (MSS) metastatic colorectal … J Ye, C Wang, C Egelston, W Guo, PP Lee, M Fakih Cancer Research 83 (7_Supplement), 6676-6676, 2023 | 1 | 2023 |
| Comparative analysis of tumor immune microenvironment in primary tumors vs metastatic tissue in microsatellite stable metastatic colorectal cancer. M Fakih, J Ye, C Wang, A Ashok, E Mauer, CY Chao Journal of Clinical Oncology 41 (4_suppl), 187-187, 2023 | 1 | 2023 |
